Teladoc Health Inc

$19.00

Want a discount? Become a member by purchasing Annual Subscription!
SKU: TDOC-1 Category:

Description

Teladoc Health, Inc. delivered mixed results for the previous quarter, with revenues below the analyst consensus. However, it managed to surpass Wall Street’s earnings expectations. The company reported an impressive 8% year-over-year growth in consolidated revenue, reaching $660 million for the third quarter. The Integrated Care segment contributed significantly, with a 9% increase in revenue to $374 million. This growth and strategic efforts to enhance margins led to surpassing expectations, with consolidated adjusted EBITDA reaching $89 million. BetterHelp, achieving $286 million in revenue, experienced an 8% YoY growth. The company highlighted robust client demand for its whole-person care solution, noting positive booking trends, especially in Chronic Care sales, which now constitute over half of total US bookings. The success of bundled solutions, such as the Diabetes Plus bundle, has streamlined contracting, improved engagement, and contributed to a 13% YoY growth in total chronic care program enrollment. Teladoc’s growth extended beyond its existing client base, with competitive takeaways adding almost 4 million lives to its virtual care programs during the third quarter.

Our Report Structure:

⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures

Want unlimited access to our reports? Purchase our $99 annual subscription!